Is cyclophosphamide effective in patients with IgM-positive minimal change disease?

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F12%3A10124638" target="_blank" >RIV/00179906:_____/12:10124638 - isvavai.cz</a>

Result on the web

<a href="http://link.springer.com/article/10.1007/s00467-012-2234-5?null#page-1" target="_blank" >http://link.springer.com/article/10.1007/s00467-012-2234-5?null#page-1</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/s00467-012-2234-5" target="_blank" >10.1007/s00467-012-2234-5</a>

Result language

angličtina

Original language name

Is cyclophosphamide effective in patients with IgM-positive minimal change disease?

Original language description

We analyzed the impact of immunoglobulin M (IgM) positivity on relapse-free interval post completed course of cyclophosphamide (CYC) treatment in patients with steroid-dependent nephrotic syndrome (SDNS) and minimal change disease (MCD). Based on our results, we conclude that more than 50% of our SDNS patients with MCD remained relapse-free 4 years post-CYC treatment. No significant difference in the response to CYC was observed between patients with or without IgM positivity.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FG - Paediatrics

OECD FORD branch

—

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2012

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Pediatric Nephrology

ISSN

0931-041X

e-ISSN

—

Volume of the periodical

27

Issue of the periodical within the volume

12

Country of publishing house

DE - GERMANY

Number of pages

5

Pages from-to

2227-2231

UT code for WoS article

000310829700008

EID of the result in the Scopus database

—